Hepatitis B virus (HBV) causes serious liver disease in man. More than 10% of the world's population are estimated to be or have been infected. HBV may also be a causative agent for the development of liver cancer (hepatoma). The virions can be isolated from patients' blood, and so studies on their structure have been feasible (Robinson et al., 1982) . Efforts to culture HBV in vitro have been unsuccessful; thus, little is known about virus assembly.
However, systems for incomplete virus replication exist. One of them, the human hepatoma cell line PLC/PRF/5 (Macnab et al., 1976) , contains HBV DNA specific for the surface antigen (HBsAg) and the core antigen (HBcAg) both extrachromosomally (Zaslavsky et al., 1980; Marquardt et al., 1982) and integrated into chromosomes (Edman et al., 1980; Miller & Robinson, 1983) . HBsAg is produced by the cells and functionally active genes were found among the HBV DNA copies integrated into the chromosomes (Dejean et al., 1983; Koshy et al., 1983) . The other known virus antigens, HBcAg and the closely related (MacKay et al., 1981; Budkowska & Karwowska, 1982 ) 'e' antigen (HBeAg), could not be detected in the cells (Skelly et al., 1979; Hofschneider et al., 1979; Marion et al., 1979) and HBcAg-specific mRNA is apparently absent (Edman et al., 1980) . HBcAg-specific DNA has been found to be preferentially methylated in PLC/PRF/5 cells (Miller & Robinson, 1983) and treatment of the cells with 5'-azacytidine, an agent known to prevent cytosine methylation (Jones & Taylor, 1980; Razin & Riggs, 1980) , has recently resulted in the production of HBcAg (Yoakum et al., 1983) . It has thus been demonstrated that PLC/PRF/5 cells contain structurally intact HBcAg-encoding genes and that expression of these genes is inducible by demethylation.
Expression of HBV DNA integrated into host cell chromosomes is also inducible by changes in environment. For instance, a cloned fragment containing integrated HBV DNA which had been isolated from an HBsAg-negative tumour was found to express HBsAg after transfer into mouse Ltk-cells (Dejean et al., 1983) . PLC/PRF/5 cells which grow as tumours in nude mice (Desmyter et al., 1978) are exposed to a different environment from cells cultured in vitro, and in this report we show that they express genes that code for HBcAg.
For the growth of cells as subcutaneous tumours, 4-to 6-week-old male athymic NMRI nu/nu mice were used which were bred in our laboratory. PLC/PRF/5 cells (7 x 106 per mouse) were injected in 0.4ml phosphate-buffered saline (PBS; 8g NaC1, 0.2g KC1, 1.15g Na2HPO4.2H20, 0.2 g KHzPO4 per 1). Tumours of 1 to 3 g developed within 6 to 8 weeks. We received other tumour-bearing NMRI nu/nu mice by courtesy of Dr J. Desmyter, Louvain, Belgium. The tumours were removed from ether-anaesthetized mice, cut into pieces of 1 to 3 mm 3, rinsed repeatedly with PBS until no further blood was removable and homogenized gently in a Dounce tissue homogenizer in 0.5 ml hypotonic buffer (HB; 10 mM-Tris-HC1 pH 7.5, 10 mM-KC1, 1.5 mM-magnesium acetate) per g tissue. The homogenization was controlled by microscopic observation. Culture of the cells in vitro was described previously (Marquardt et al., 1982) and ceils were homogenized as described above. Homogenized cells were investigated for the presence of HBsAg and HBc/HBeAg using radioimmunoassays (RIA). HBc/HBeAg was monitored by the HBe RIA test kit (which does not discriminate between HBcAg and HBeAg) and HBsAg by the Ausria I1-125 test kit (both from Abbott Laboratories, North Chicago, II1., U.S.A.) as recommended by the supplier. Both in vitro and in vivo cultured cells produced high levels of HBsAg. Cells grown in vitro did not contain HBc/HBeAg (ratio to negative control, P/N = 1.1), but when tumour homogenates (0-4g cells/assay) were analysed low amounts of HBc/HBeAg could be detected (P/N = 2.1 to 2.5). Sera prepared from 0.6 to 0.9 ml of the blood of the mice used to culture tumours were also investigated for their content of HBe/HBcAg by RIA but were found to be negative (P/N < 1.8).
The positive material was concentrated by isopycnic CsC1 equilibrium centrifugation (60 h at 35000 r.p.m, at 4 °C in a Beckman SW60 rotor) of cell homogenate prepared from 3 g of HBc/HBeAg-positive tumours. Ten fractions were collected from the bottom and assayed for HBc/HBeAg by RIA (Fig. l a) . Fractions 3 to 8 were clearly positive. Cell homogenates Short communication i445 prepared either from tissue-cultured PLC/PRF/5 cells or from the livers of untreated nude mice were also centrifuged in CsC1 and gave negative results. Precise determination of the buoyant density in CsC1 of HBc/HBeAg was hindered by overloading of the gradient. The buoyant density in CsC1 of HBsAg and HBcAg indicates whether they are associated with viral particles. The virion (Dane particle) contains HBsAg and HBcAg and bands at 1.25 g/ml (Hruska & Robinson, 1977) ; the HBcAg-containing core particles band at above 1.3 g/ml (Gerin & Shih, 1978) and HBsAg at 1-2 g/ml (Skelly et al., 1979; Hofschneider et al., 1979) .
Homogenates corresponding to 0.3 g tumour were centrifuged in CsC1 as described above (Fig. 1 a) . Fractions were collected and analysed for HBc/HBeAg and HBsAg by RIA (Fig. 1 b) . Fraction 10 was the only one positive for HBc/HBeAg and corresponded to a buoyant density of 1.31 to 1.32 g/ml, which is similar to that of core particles. HBsAg mainly banded at about 1-2 g/ml, its known density.
In order to evaluate the specificity of the immune reaction observed with the PLC/PRF/5 tumour homogenates a blocking experiment was done with fractions of a parallel CsC1 gradient (Table 1 ). This was done by incubating the samples (150 gl) for 6 h at 21 °C with 50 ~tl of a recalcified anti-HBe-and anti-HBc-positive plasma (MWW; Fr6sner et al., 1978) or with 50 ~tl of a recalcified plasma free of all HBV markers, prior to overnight incubation at 21 °C with beads coated with anti-HBc and anti-HBe. The beads were washed five times with 3 ml PBS each time, and incubated overnight at 21 °C with 200 I~1 12SI-labelled anti-HBe-and anti-HBcpositive IgG which was supplemented by 1 mg/ml of aggregated IgG negative for HBV markers. Radioactivity was measured in a Kontron MR 252 automatic gamma-counting system. Results are presented as c.p.m. As can be seen (Table 1) , HBc/HBeAg present in fractions 4 to 6 was blocked by preincubation with an anti-HBe-and anti-HBc-positive plasma but not with an anti-HBe-, anti-HBc-and anti-HBs-negative plasma. These results indicate that the observed reactivity is specific for HBc/HBeAg.
A fraction of another CsC1 gradient containing PLC/PRF/5 tumour homogenate which was positive for HBc/HBeAg was investigated by a separate test system, the Corab RIA (Abbott Laboratories), and found again to be positive (not shown). In our hands, positive results were occasionally obtained also with control HBeAg (G. Fr6sner, unpublished results). Presence of this antigen in the turnout homogenate thus cannot be excluded.
The intracellular localization on HBc/HBeAg was investigated since it has been found predominantly in the nuclei of HBV-infected hepatocytes (Gerin & Shih, 1978) . A cell homogenate prepared from 2.5 g tumour was separated by centrifugation (15000 g for 20 min) into a nuclei-containing pellet and a supernatant containing material from the cytoplasm. Both cell fractions were submitted to CsC1 gradient centrifugation. Fractions were analysed for HBc/HBeAg by RIA. The combined peak fractions (5 + 6) from the nuclear gradient had a P/N ratio of 3.9 compared to a P/N ratio of 5.7 from the cytoplasmic material gradient. It thus appears that HBc/HBeAg is located in the cytoplasm as well as in the nucleus of a cell. Considering the volume of a cell and its nucleus, it is concluded that concentration of HBc/HBeAg in nuclei is higher than in the cytoplasm.
It was of interest to see whether the production of HBc/HBeAg continued when nude mouse tumour-derived cells were passaged in vitro. Two g of such cells, homogenized and assayed as (a) (b) Fig. 2 . Hybridization of HBV probe to DNA prepared from in vitro cultured (a) and nude mouse tumour-derived (b) PLC/PRF/5 ceils. Ten Ixg of each genomic DNA was digested with HindlII, electrophoresed through a 1% agarose gel, transferred to a nitrocellulose filter and hybridized to nicktranslated HBV-specific DNA (sp. act. 5 x l0 s 3zp c.p.m./p~g) purified from pAO1-HBV (Cummings et al., 1980) . described in Fig. 1 (a) were negative for HBc/HBeAg (not shown). Cells derived from the same passage were cloned in soft agar (twice), cultured in vitro and further as a nude mouse tumour. These cells (2 g) were again positive for HBc/HBeAg (P/N ratio of the peak fractions 4 = 2.5, 5 = 3-5, 6 = 3.0).
Since only PLC/PRF/5 cells grown as nude mouse tumours produced HBc/HBeAg they must differ from tissue-cultured cells. Whether rearrangement of genes accounts for the differences was investigated. 
